Wolverine Trading, LLC Liquidia Corp Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$8.9 - $14.11 $44,500 - $70,550	5,000 Added 35.97%	18,900 $189,000
Q2 2024 Aug 14, 2024	SELL	$11.96 - $15.71 $59,800 - $78,550	-5,000 Reduced 26.46%	13,900 $166,000
Q1 2024 May 15, 2024	SELL	$11.35 - $16.73 $173,655 - $255,969	-15,300 Reduced 44.74%	18,900 $278,000
Q4 2023 Feb 14, 2024	BUY	$5.77 - $12.19 $70,394 - $148,718	12,200 Added 55.45%	34,200 $411,000
Q3 2023 Nov 15, 2023	BUY	$6.27 - $8.15 $58,310 - $75,795	9,300 Added 73.23%	22,000 $139,000
Q2 2023 Aug 23, 2023	BUY	$6.63 - $9.9 $84,201 - $125,730	12,700 New	12,700 $99,000

171

44.3M

1.55M

1.52M

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $735M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.